Company · CIK 1515673
Ultragenyx Pharmaceutical Inc.
| CIK | 1515673 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | RARE (Nasdaq) |
| First annual or quarterly report | 2014-03-24 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-277226 | 2024-02-21 | 2024-06-14 | 3 | |
| 333-253008 | 2021-02-12 | 2023-10-20 | 4 | |
| 333-223123 | 2018-02-21 | 2020-10-29 | 6 | |
| 333-201838 | 2015-02-03 | 2018-01-24 | 9 | |
| 333-197008 | 2014-06-25 | 2014-07-09 | 4 | |
| 333-192244 | 2013-11-08 | 2014-01-31 | 6 |
Filings
33| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-06-14 | 424B5Shelf takedown | 333-277226 | 0001193125-24-161716 |
| 2024-06-12 | 424B5Shelf takedown | 333-277226 | 0001193125-24-160052 |
| 2024-02-21 | S-3ASRShelf registered | 333-277226 | 0001193125-24-041577 |
| 2023-10-20 | 424B5Shelf takedown | 333-253008 | 0001193125-23-259557 |
| 2023-10-17 | 424B5Shelf takedown | 333-253008 | 0001193125-23-257669 |
| 2021-05-07 | 424B5Shelf takedown | 333-253008 | 0001193125-21-154979 |
| 2021-02-12 | S-3ASRShelf registered | 333-253008 | 0001193125-21-038956 |
| 2020-10-29 | 424B5Shelf takedown | 333-223123 | 0001193125-20-281028 |
| 2020-10-28 | 424B5Shelf takedown | 333-223123 | 0001193125-20-279186 |
| 2019-02-27 | 424B5Shelf takedown | 333-223123 | 0001193125-19-054001 |
| 2019-02-25 | 424B5Shelf takedown | 333-223123 | 0001193125-19-049875 |
| 2018-03-30 | 424B5Shelf takedown | 333-223123 | 0001193125-18-103333 |
| 2018-02-21 | S-3ASRShelf registered | 333-223123 | 0001193125-18-051916 |
| 2018-01-24 | 424B5Shelf takedown | 333-201838 | 0001193125-18-018465 |
| 2018-01-23 | 424B5Shelf takedown | 333-201838 | 0001193125-18-016653 |
| 2017-07-28 | 424B5Shelf takedown | 333-201838 | 0001193125-17-238795 |
| 2016-07-01 | 424B5Shelf takedown | 333-201838 | 0001193125-16-640491 |
| 2015-07-17 | 424B5Shelf takedown | 333-201838 | 0001193125-15-255077 |
| 2015-07-14 | 424B5Shelf takedown | 333-201838 | 0001193125-15-252397 |
| 2015-02-05 | 424B5Shelf takedown | 333-201838 | 0001193125-15-035437 |
| 2015-02-04 | 424B5Shelf takedown | 333-201838 | 0001193125-15-032303 |
| 2015-02-03 | S-3ASRShelf registered | 333-201838 | 0001193125-15-031600 |
| 2014-07-09 | 424B4Final prospectus | 333-197008 | 0001193125-14-263576 |
| 2014-07-08 | EFFECTDeclared effective | 333-197008 | 9999999995-14-002086 |
| 2014-07-07 | S-1/AAmendment | 333-197008 | 0001193125-14-261974 |
| 2014-06-25 | S-1Registration filed | 333-197008 | 0001193125-14-247964 |
| 2014-01-31 | 424B4Final prospectus | 333-192244 | 0001193125-14-029425 |
| 2014-01-30 | EFFECTDeclared effective | 333-192244 | 9999999995-14-000258 |
| 2014-01-30 | S-1/AAmendment | 333-192244 | 0001193125-14-027263 |
| 2014-01-17 | S-1/AAmendment | 333-192244 | 0001193125-14-014673 |
| 2013-12-23 | S-1/AAmendment | 333-192244 | 0001193125-13-482988 |
| 2013-11-08 | S-1Registration filed | 333-192244 | 0001193125-13-435507 |
| 2013-10-04 | DRSDraft made public | 377-00334 | 0000950123-13-007701 |